American Thyroid Association surveys patients for satisfaction levels on treatment for hypothyroidism May 7, 2018—In…
Read More
The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for…
FREE ACCESS through May 7, 2018. Read now: Latest Impact Factor: 5.515 The Official Journal…
From Clinical Thyroidology® for the Public: A patient survey of hypothyroid individuals demonstrates dissatisfaction with…
ATA supports dialogue on the international harmonization of radiological emergency preparedness around nuclear power stations…
FREE ACCESS through April 30, 2018. Read Now: Circulating BRAF V600E Levels Correlate with Treatment…
FREE ACCESS through April 13, 2018. Read Now: No Benefit of Levothyroxine Among Pregnant Hypothyroid…
FREE ACCESS through April 5, 2018. Read now: Latest Impact Factor: 5.515 The Official Journal…
From Clinical Thyroidology® for the Public: In 1–2% of PET scans performed for the diagnosis…
VideoEndocrinology™ The Official Journal of: American Thyroid Association FREE ACCESS through March 12, 2018. Watch…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.